(1)
Mazen M. Dimachkie. Optimizing Chronic Inflammatory Demyelinating Polyneuropathy Care With Subcutaneous Immunoglobulin: The Polyneuropathy and Treatment With Hizentra Open-Label Extension (PATH OLE) Study and Beyond. rrnmf 2022, 3 (2), 13-26. https://doi.org/10.17161/rrnmf.v3i2.16304.